RGS4 exerts inhibitory activities on the signaling of dopamine D 2 receptor and D 3 receptor through the N-terminal region

Pharmacological Research

Volumn 65, Issue 2, 2012, Pages 213-220

  Min, Chengchun ^a   Cheong, Sang Yoon ^a   Cheong, Soo Jin ^a   Kim, Munsoo ^a   Cho, Dong Im ^a   Kim, Kyeong Man ^a  

^a Chonnam National University   (South Korea)

Author keywords

Desensitization; Dopamine D 2 and D 3 receptor; Internalization; RGS proteins; Signaling

Indexed keywords

DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; RGS2 PROTEIN; RGS4 PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING AFFINITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EMBRYO; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; INTERNALIZATION; INTRACELLULAR SIGNALING; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS INHIBITION;

ANIMALS; HEK293 CELLS; HUMANS; MALE; PROTEIN INTERACTION DOMAINS AND MOTIFS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; RGS PROTEINS; SIGNAL TRANSDUCTION;

EID: 84855996266     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2011.08.008     Document Type: Article

References (35)

1. 2+ channel inhibition in rat striatal cholinergic interneurons Proc Natl Acad Sci U S A 101 2004 16339 16344 (Pubitemid 39552846)
2. D.B. Calne, P.F. Teychenne, P.N. Leigh, A.N. Bamji, and J.K. Greenacre Treatment of parkinsonism with bromocriptine Lancet 2 1974 1355 1356
3. P.L. Carlton, and P. Manowitz Dopamine and schizophrenia: an analysis of the theory Neurosci Biobehav Rev 8 1984 137 151 (Pubitemid 14118786)
4. 2-dopamine receptors J Neurochem 114 2010 739 749
5. M.L. Cheever, J.T. Snyder, S. Gershburg, D.P. Siderovski, T.K. Harden, and J. Sondek Crystal structure of the multifunctional Gbeta5-RGS9 complex Nat Struct Mol Biol 15 2008 155 162 (Pubitemid 351227317)
6. D. Cho, M. Zheng, C. Min, L. Ma, H. Kurose, and J.H. Park Agonist-induced endocytosis and receptor phosphorylation mediate resensitization of dopamine D(2) receptors Mol Endocrinol 24 2010 574 586
7. 3 receptor and elongation factor-1Bbetagamma Life Sci 73 2003 2991 3004 (Pubitemid 37176891)
8. D.I. Cho, M. Zheng, and Kim KM Current perspectives on the selective regulation of dopamine D and D receptors Arch Pharm Res 33 2010 1521 1538
9. 3 receptor Mol Endocrinol 21 2007 2242 2254 (Pubitemid 47347385)
10. D. Cunnah, and M. Besser Management of prolactinomas Clin Endocrinol (Oxf) 34 1991 231 235
11. H.A. Erdely, R.A. Lahti, M.B. Lopez, C.S. Myers, R.C. Roberts, and C.A. Tamminga Regional expression of RGS4 mRNA in human brain Eur J Neurosci 19 2004 3125 3128 (Pubitemid 38822605)
12. M.G. Hearn, Y. Ren, E.W. McBride, I. Reveillaud, M. Beinborn, and A.S. Kopin A Drosophila dopamine 2-like receptor: molecular characterization and identification of multiple alternatively spliced variants Proc Natl Acad Sci U S A 99 2002 14554 14559 (Pubitemid 35257709)
13. S.P. Heximer, S.P. Srinivasa, L.S. Bernstein, J.L. Bernard, M.E. Linder, and J.R. Hepler G protein selectivity is a determinant of RGS2 function J Biol Chem 274 1999 34253 34259 (Pubitemid 129511765)
14. 5 receptors expressed in stable cAMP-responsive luciferase reporter cell lines J Recept Res 13 1993 79 94 (Pubitemid 23081908)
15. O. Hornykiewicz Dopamine (3-hydroxytyramine) in the central nervous system and its relation to the Parkinson syndrome in man Dtsch Med Wochenschr 87 1962 1807 1810
16. 3 receptor signaling by modulating the stability of a receptor-filamin-beta-arrestin complex. A case of autoreceptor regulation J Biol Chem 280 2005 12774 12780
17. 3 receptors by G protein-coupled receptor kinases and beta-arrestins J Biol Chem 276 2001 37409 37414
18. 2 dopamine receptors colocalize regulator of G-protein signaling 9-2 (RGS9-2) via the RGS9 DEP domain, and RGS9 knock-out mice develop dyskinesias associated with dopamine pathways J Neurosci 25 2005 2157 2165 (Pubitemid 40289421)
19. S. Matthysse Antipsychotic drug actions: a clue to the neuropathology of schizophrenia? Fed Proc 32 1973 200 205
20. 2 receptor through direct interaction with {beta}-catenin Mol Pharmacol 80 2011 68 78
21. K. Mirnics, F.A. Middleton, G.D. Stanwood, D.A. Lewis, and P. Levitt Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia Mol Psychiatry 6 2001 293 301 (Pubitemid 32275674)
22. Y. Nomura, I. Yotsumoto, and T. Segawa High potassium-induced, calcium-dependent monoamine release from brain slices of the newborn rat Jpn J Pharmacol 29 1979 847 854 (Pubitemid 10185636)
23. K.M. Prasad, L. Almasy, R.C. Gur, R.E. Gur, M. Pogue-Geile, and K.V. Chowdari RGS4 polymorphisms associated with variability of cognitive performance in a family-based schizophrenia sample Schizophr Bull 36 2009 983 990
24. Z. Rahman, J. Schwarz, S.J. Gold, V. Zachariou, M.N. Wein, and K.H. Choi RGS9 modulates dopamine signaling in the basal ganglia Neuron 38 2003 941 952 (Pubitemid 36782384)
25. 2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum Proc Natl Acad Sci U S A 104 2007 654 659 (Pubitemid 46123080)
26. E. Schiorring An open field study of stereotyped locomotor activity in amphetamine-treated rats Psychopharmacology (Berl) 66 1979 281 287 (Pubitemid 10173625)
27. P. Seeman Dopamine receptors and the dopamine hypothesis of schizophrenia Synapse (New York, NY) 1 1987 133 152 (Pubitemid 17119661)
28. P. Seeman, and H.B. Niznik Dopamine receptors and transporters in Parkinson's disease and schizophrenia FASEB J 4 1990 2737 2744
29. M.E. Talkowski, H. Seltman, A.S. Bassett, L.M. Brzustowicz, X. Chen, and K.V. Chowdari Evaluation of a susceptibility gene for schizophrenia: genotype based meta-analysis of RGS4 polymorphisms from thirteen independent samples Biol Psychiatry 60 2006 152 162 (Pubitemid 44043148)
30. J.M. Taymans, H.K. Kia, R. Claes, C. Cruz, J. Leysen, and X. Langlois Dopamine receptor-mediated regulation of RGS2 and RGS4 mRNA differentially depends on ascending dopamine projections and time Eur J Neurosci 19 2004 2249 2260 (Pubitemid 38582213)
31. 2 receptors: clues for RGS2 and RGS4 functions J Neurochem 84 2003 1118 1127 (Pubitemid 36330664)
32. 3 dopamine receptor is determined by specific amino acid residues in the second cytoplasmic loop Biochim Biophys Acta 1773 2007 1747 1758 (Pubitemid 350199574)
33. R.A. Wise The role of reward pathways in the development of drug dependence Pharmacol Ther 35 1987 227 263 (Pubitemid 18013045)
34. X. Xu, W. Zeng, S. Popov, D.M. Berman, I. Davignon, and K. Yu RGS proteins determine signaling specificity of Gq-coupled receptors J Biol Chem 274 1999 3549 3556 (Pubitemid 29077196)
35. W. Zeng, X. Xu, S. Popov, S. Mukhopadhyay, P. Chidiac, and J. Swistok The N-terminal domain of RGS4 confers receptor-selective inhibition of G protein signaling J Biol Chem 273 1998 34687 34690 (Pubitemid 29028156)